Table 1.
GeneXpert Mycobacterium tuberculosis/rifampicin machine distribution, and demographic and clinical characteristics of patients
| Variables | Frequency (%) |
|---|---|
| Type of health facility (n=366) | |
| Public | 318 (86.9) |
| Private | 48 (13.1) |
| Level of health facility | |
| Primary | 23 (6.3) |
| Secondary | 287 (78.4) |
| Tertiary | 56 (15.3) |
| Utilization, test outcomes (n=354,321) | |
| Successful | 324,248 (91.5) |
| Unsuccessful | 30,073 (8.5) |
| Bacteriology and drug resistance profile | |
| MTB not detected | 270,225 (83.2) |
| MTB detected | 54,713 (16.8) |
| MTB detected, RIF resistance negative | 50,292 (91.9) |
| MTB detected RIF resistance positive | 3731 (6.8) |
| MTB detected RIF resistance indeterminate | 690 (1.3) |
| Unsuccessful test outcome category | |
| Invalid | 5207 (1.5) |
| Error | 24,176 (6.8) |
| Indeterminate | 690 (0.2) |
| Age, years, median (IQR) | 33 (24-48) |
| Gender (n=90,783) | |
| Male | 46,230 (50.9) |
| Female | 44,553 (49.1) |
| HIV status of patients tested (n=64,389) | |
| Positive | 14,901 (23.1) |
| Negative | 49,488 (76.9) |
MTB – Mycobacterium tuberculosis; RIF – Rifampicin; HIV – Human immunodeficiency virus; IQR – Interquartile range